Malaria Prophylaxis — Comparing Prevention Medications
Malaria kills over 600,000 people annually and remains one of the greatest health risks for travelers to Sub-Saharan Africa, South and Southeast Asia, and parts of Central and South America. No antimalarial is 100% effective, but taking prophylaxis reduces the risk of infection by 90–99% when combined with bite prevention measures.
Three antimalarial medications are commonly prescribed for travelers. Each has different dosing schedules, side effect profiles, costs, and suitability for specific populations. This guide helps you understand the differences so you can have an informed conversation with your travel health provider.
Prescription Required
All antimalarial medications require a prescription. Do not self-medicate. Your doctor will choose the right medication based on your destination (chloroquine resistance patterns), medical history, other medications, pregnancy status, and trip duration. This article is for educational purposes to help you understand your options.
Head-to-Head Comparison
The three main antimalarials for travelers are atovaquone-proguanil (Malarone®), doxycycline, and mefloquine (Lariam®). Here is how they compare across key factors:
Atovaquone-Proguanil (Malarone®)
Dosing: 1 tablet daily. Start 1–2 days before entering the malaria zone, take daily during the stay, and continue for 7 days after leaving. This is the shortest post-travel course of any antimalarial.
Side effects: Generally the best-tolerated antimalarial. Common: nausea, abdominal pain, headache (usually mild and transient). Rare: mouth ulcers, elevated liver enzymes. Take with food or a milky drink to improve absorption and reduce nausea.
Pros: Fewest side effects, shortest post-travel course (7 days vs 28), well-tolerated, can be used short-term and long-term (approved up to 12 months). Good for last-minute travelers (only 1–2 days lead time).
Cons: Most expensive option (€3–5 per tablet, ~€100–150 for a 4-week trip). Daily dosing required (easy to forget). Not recommended in severe renal impairment (GFR <30).
Pregnancy: Insufficient data — not recommended in pregnancy or breastfeeding mothers of infants <5 kg. Use mefloquine or chloroquine instead.
Children: Approved from 5 kg body weight (pediatric tablets available). Weight-based dosing.
Doxycycline
Dosing: 100 mg daily. Start 1–2 days before entering the malaria zone, take daily during the stay, and continue for 28 days after leaving.
Side effects: Photosensitivity (increased sunburn risk — use SPF 50+ and avoid prolonged sun exposure). Gastrointestinal upset (take with food, remain upright for 30 minutes after). Vaginal yeast infections in women. Esophageal ulceration if taken without water or lying down. Rarely: headache.
Pros: Cheapest option (€0.10–0.50 per tablet). Also protects against bacterial infections, acne, and leptospirosis. Widely available globally. Effective against chloroquine-resistant malaria. Long track record.
Cons: 28-day post-travel course (easy to forget or abandon). Photosensitivity is a real problem in tropical destinations with intense sun. GI side effects can be troublesome. Not suitable for long trips if cost is the only factor — the 28-day tail adds up.
Pregnancy: Contraindicated in pregnancy (risk of tooth discoloration and bone growth effects on the fetus) and breastfeeding.
Children: Not recommended for children under 8 years (risk of permanent tooth staining).
Mefloquine (Lariam®)
Dosing: 250 mg once weekly. Start 2–3 weeks before travel (to test tolerance and build up blood levels), take weekly during the stay, and continue for 4 weeks after leaving.
Side effects: Neuropsychiatric effects are the main concern: vivid dreams, insomnia, anxiety, depression, dizziness, and (rarely) psychosis or seizures. GI effects: nausea, vomiting, diarrhea. Most side effects occur within the first 3 doses — this is why the 2–3 week lead time is important (you can switch if intolerant).
Pros: Weekly dosing (most convenient schedule). Moderate cost (€2–4 per tablet, ~€15–20 for a 4-week trip). Only option for long-term travelers who need pregnancy-safe prophylaxis. Can be used for trips of any duration.
Cons: Neuropsychiatric side effects (5–25% of users report some symptoms). Requires 2–3 week lead time. Contraindicated in depression, anxiety disorders, psychosis, seizure disorders, and cardiac conduction abnormalities. FDA black box warning for neuropsychiatric effects. 4-week post-travel course.
Pregnancy: Safe in all trimesters of pregnancy and during breastfeeding. This makes mefloquine the preferred option for pregnant travelers to chloroquine-resistant malaria areas.
Children: Approved from 5 kg body weight. Weight-based dosing. Weekly dosing is often easier for families.
How to Choose: Decision Guide
Short trip (1—2 weeks), budget not a concern: Atovaquone-proguanil. Fewest side effects, shortest post-travel course.
Budget-conscious traveler, sun exposure not extreme: Doxycycline. 10–30× cheaper than Malarone. Added benefit of antibiotic protection.
Long-term travel (>3 months): Mefloquine (weekly dosing, moderate cost) or doxycycline (cheapest). Atovaquone-proguanil is approved up to 12 months but cost is prohibitive for long trips.
Pregnant travelers: Mefloquine (safe in all trimesters) or chloroquine (where still effective). Doxycycline and atovaquone-proguanil are contraindicated.
Children under 8: Atovaquone-proguanil (≥5 kg) or mefloquine (≥5 kg). Doxycycline is contraindicated.
History of depression or anxiety: Avoid mefloquine. Choose atovaquone-proguanil or doxycycline.
Last-minute travel: Atovaquone-proguanil or doxycycline (both need only 1–2 days lead time). Mefloquine needs 2–3 weeks.
What About Chloroquine?
Chloroquine was once the standard antimalarial but is now ineffective in most malaria-endemic regions due to widespread Plasmodium falciparum resistance. It remains effective only in parts of Central America (west of the Panama Canal), the Caribbean, and some areas of the Middle East. If traveling to these specific regions, chloroquine is safe, cheap, and well-tolerated. For all other destinations, use one of the three medications above.
Standby Emergency Treatment (SBET)
Some travel health providers prescribe standby emergency treatment — a full treatment course of antimalarials to carry in case you develop malaria symptoms and cannot reach medical care within 24 hours. This is NOT a substitute for prophylaxis. SBET is typically prescribed for: travelers to low-risk areas where prophylaxis may not be warranted, long-term travelers after completing prophylaxis, and travelers to very remote areas far from hospitals.
Do Not Buy Antimalarials Locally in Endemic Countries
Counterfeit and substandard antimalarials are a serious problem in many malaria-endemic countries. WHO estimates that up to 30% of antimalarials in Sub-Saharan Africa are fake or substandard. Always obtain your medication from a reputable pharmacy in your home country before departure. If you must buy locally, use hospital pharmacies in major cities.
Key Reminders
No antimalarial provides 100% protection. Always combine prophylaxis with bite prevention: insect repellent (DEET or picaridin), permethrin-treated clothing, insecticide-treated bed nets, and staying in screened or air-conditioned rooms between dusk and dawn. If you develop fever within 3 months of returning from a malaria-endemic area, seek urgent medical attention and tell the doctor you have been in a malaria zone — even if you took prophylaxis.